Medicare Prescription Drug Price Negotiation Act
United States legislation
From Wikipedia, the free encyclopedia
In January 2007, the 110th United States House of Representatives approved H.R. 4, the Medicare Prescription Drug Price Negotiation Act,[1] a bill to require federal officials to negotiate with drug companies for lower prices for the 23 million senior citizens who have signed up for Medicare's prescription drug coverage. The bill was never passed into law. It would have repealed a ban on letting the government negotiate with manufacturers for lower prices — a provision that was part of the GOP-sponsored 2003 measure called the Medicare Prescription Drug, Improvement, and Modernization Act, which created the prescription drug program.[2] Medicare drug price negotiation was eventually authorized in 2022 as part of the Inflation Reduction Act.
Legislative history
| Congress | Short title | Bill number(s) | Date introduced | Sponsor(s) | # of cosponsors | Latest status |
|---|---|---|---|---|---|---|
| 110th Congress | Medicare Prescription Drug Price Negotiation Act of 2007 | H.R. 4 | January 5, 2007 | John Dingell
(D-MI) |
198 | Passed House (255-170)[3] |
| S. 3 | January 4, 2007 | Harry Reid
(D-NV) |
17 | Cloture not invoked (55-42) | ||
| 111th Congress | Medicare Prescription Drug Price Negotiation Act of 2010 | H.R. 4752 | March 3, 2010 | Peter Welch
(D-VT) |
81 | Died in committee |
| S. 3413 | May 25, 2010 | Russ Feingold
(D-WI) |
0 | Died in committee | ||
| 112th Congress | Medicare Prescription Drug Price Negotiation Act of 2011 | H.R. 2248 | June 21, 2011 | Peter Welch
(D-VT) |
29 | Died in committee |
| S. 44 | January 25, 2011 | Amy Klobuchar
(D-MN) |
8 | Died in committee | ||
| 113th Congress | Medicare Prescription Drug Price Negotiation Act of 2013 | H.R. 1102 | March 12, 2013 | Peter Welch
(D-VT) |
40 | Died in committee |
| S. 117 | January 23, 2013 | Amy Klobuchar
(D-MN) |
8 | Died in committee | ||
| 114th Congress | Medicare Prescription Drug Price Negotiation Act of 2015 | H.R. 3061 | July 14, 2015 | Peter Welch
(D-VT) |
33 | Died in committee |
| S. 31 | January 6, 2015 | Amy Klobuchar
(D-MN) |
9 | Died in committee | ||
| 115th Congress | Medicare Prescription Drug Price Negotiation Act of 2017 | H.R. 242 | January 4, 2017 | Peter Welch
(D-VT) |
45 | Died in committee |
| S. 41 | January 5, 2017 | Amy Klobuchar
(D-MN) |
13 | Died in committee | ||
| 116th Congress | Medicare Prescription Drug Price Negotiation Act of 2019 | H.R. 275 | January 8, 2019 | Peter Welch
(D-VT) |
37 | Died in committee |
| 117th Congress | Medicare Prescription Drug Price Negotiation Act of 2021 | H.R. 2071 | March 18, 2021 | Peter Welch
(D-VT) |
12 | Died in committee |
No bill carrying the Medicare Prescription Drug Price Negotiation Act title was introduced in the 118th or 119th Congresses, following enactment of Medicare drug price negotiation through other legislation in 2022.
Enactment via the Inflation Reduction Act
None of the bills above became law. The policy was instead enacted in 2022 through the Inflation Reduction Act (IRA; H.R. 5376), which directs the Secretary of Health and Human Services to negotiate prices with manufacturers for selected high-spending drugs covered under Medicare Part D and, beginning in 2028, Medicare Part B.[4]
